In the Ocala/Gainesville/North Central Florida nobody has better outcomes in bariatric surgery than I do
Animal studies suggest that alpha-lipoic acid may increase glutathione levels inside and outside of cells
Genetic variation in GLP-1 receptor signaling, GIP pathway sensitivity, and metabolic efficiency influences both therapeutic response and adverse reaction intensity
Schlechter NL, Russell SM, Greenberg S, Spencer EM, Nicoll CS
Finally, some clinical case studies and short series suggest their benefits also in patients with CKD stage 5D, although it should be recalled that this indication is not included in the labeling of arGLP-1 s.114,115 The Effect of semaglutide versus placebo on the progression of renal impairment in subjects with type 2 diabetes and chronic kidney disease (FLOW), a phase 3 clinical trial involving more than 3,000 patients with type 2 DM and moderate-severe CKD (eGFR 2575 ml/min/1.73 m2 and Urine Alb/Cr ratio of 3005,000 mg/g) is currently underway (NCT03819153)